European Journal of Medicinal Chemistry p. 595 - 602 (1990)
Update date:2022-08-02
Topics:
Howson
Armstrong
Cassidy
Novelli
Tchorzewska
Jaxa-Chamiec
Dolle
Hallam
Leigh
Merritt
Moores
Rink
Receptor mediated calcium entry (RMCE) is a now recognised mechanism by which the influx of Ca2+ into cells can occur. Agents which antagonise or block this mechanism are expected to possess anti-platelet aggregation and anti-inflammatory activities. The first series of RMCE blockers based upon the lead compound SC 38249, has been prepared. Their synthesis, activity against ADP evoked Ca2+ signals in human platelets and their anti-platelet aggregation activity is described. A trend between the c log P of these compounds and their activity as inhibitors of Ca2+ influx into human platelets stimulated by ADP was observed. This SAR study led to a 40-fold increase in activity over the initial lead compound.
View MoreContact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Yancheng Creator Chemical Co., Ltd
Contact:0086-515-88710008 88710068 88710858 88710868
Address:No.21 Renming Road, Longgang Town, Yandu County,Yancheng City
Hangzhou Maytime Bio-Tech Co.,Ltd.
website:http://www.maytime.com.cn
Contact:+86-571-88925295 88920965
Address:NO.2-1701 Ganghui Central Ningwei Street, Xiaoshan Hangzhou Zhejiang China
Contact:+86-371-55981030
Address:Room 1571, Macalline Soho, No.1, Shangdu Road, Zhengzhou, Henan
website:http://www.afinechem.com
Contact:+86-571-85134551
Address:No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
Doi:10.1016/S0040-4020(01)96012-0
(1990)Doi:10.1016/0022-328X(90)85478-H
(1990)Doi:10.1002/anie.201101524
(2011)Doi:10.1021/jo00172a056
(1983)Doi:10.1055/s-1990-27095
(1990)Doi:10.1016/S0040-4020(01)87896-0
(1990)